IRF9

IRF9

Target · Transcription factor

IRF9 Interferon regulatory factor 9 · ISGF3G

IRF9 (interferon regulatory factor 9, also known as ISGF3G) is a transcription factor with an essential role in anti-viral immunity. It mediates signalling by type I interferons and forms part of the ISGF3 complex that drives interferon-stimulated gene expression. Browse Assay Genie's current range of IRF9 research reagents below, or read on for the biology behind the target.

Cytoplasm and nucleusType I IFN transcription factorLinked to immunodeficiency 65
393 aa
Protein length
~44 kDa
Molecular weight
14q12
Gene locus
IRF family
Protein family
Target information

What is IRF9 (interferon regulatory factor 9)?

IRF9 is a transcription factor that mediates signalling by type I interferons (IFN-alpha and IFN-beta). When type I IFN binds its cell surface receptors, the Jak kinases TYK2 and JAK1 are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. IRF9 then associates with the phosphorylated STAT1:STAT2 dimer to form the ISGF3 transcription factor complex, which enters the nucleus.

Within the nucleus, ISGF3 binds the IFN stimulated response element (ISRE) and activates transcription of interferon stimulated genes. These genes drive the cell into an antiviral state, which is why IRF9 is described as essential for anti-viral immunity. UniProt records the protein in both the cytoplasm and the nucleus, consistent with its movement as part of ISGF3. Researchers studying the IRF9 gene or protein often do so in the context of JAK-STAT signalling and interferon responses.

IRF9 belongs to the interferon regulatory factor (IRF) family, a group of transcription factors with diverse roles, including virus-mediated activation of interferon and modulation of cell growth, differentiation, apoptosis and immune system activity. IRF family members are characterised by a conserved N-terminal DNA-binding domain containing tryptophan (W) repeats. The gene was previously named interferon-stimulated transcription factor 3, gamma (48kD), and the symbol ISGF3G remains in use. Mutations in the gene result in Immunodeficiency 65. The mouse ortholog is Irf9.

Type I interferon signalling

IRF9 links activated STAT1 and STAT2 to the ISRE, making it central to how IFN-alpha and IFN-beta signals become transcriptional responses.

Anti-viral immunity

As a component of ISGF3, IRF9 drives interferon stimulated genes that place the cell in an antiviral state.

JAK-STAT pathway research

IRF9 acts downstream of TYK2 and JAK1 activation and STAT1 and STAT2 phosphorylation, so it is a useful readout of pathway activity.

Primary immunodeficiency

Mutations in the IRF9 gene result in Immunodeficiency 65, linking the protein to inherited defects of immune function.

Background

IRF9 frequently asked questions

What does IRF9 do?

IRF9 is a transcription factor essential for anti-viral immunity. After type I interferon signalling phosphorylates STAT1 and STAT2, IRF9 joins them to form ISGF3. This complex enters the nucleus, binds the ISRE and activates interferon stimulated genes that establish an antiviral state.

What other names does IRF9 go by?

IRF9 is also known as ISGF3G. Earlier names were interferon-stimulated transcription factor 3, gamma (48kD) and interferon-stimulated transcription factor 3, gamma 48kDa. HGNC places it in the interferon regulatory factors gene group, and UniProt describes it as a member of the IRF family.

Is IRF9 linked to disease, and is it conserved?

Mutations in the IRF9 gene result in Immunodeficiency 65. A mouse ortholog, Irf9, exists, so the pathway can be studied in mouse models; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other interferon regulatory factor family members with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q00978; product specifications from Assay Genie datasheets.

IRF9 Product listing